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all Motion in the Setting of Myocardial Stunning
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ntonio Losada, MD,* Julio Núñez, MD,* Mauricio Pellicer, MD,* Vicente Bertomeu, MD,*
rancisco J. Chorro, MD, FESC,* Àngel Llácer, MD, FESC*
alencia, Spain
OBJECTIVES We sought to evaluate the usefulness of a comprehensive assessment of four cardiovascular
magnetic resonance imaging (CMR)-derived myocardial viability indexes in the setting of
myocardial stunning.
BACKGROUND Cardiovascular magnetic resonance imaging allows the simultaneous assessment of several
viability indexes.
METHODS We studied 40 patients with a first ST-segment elevation myocardial infarction (MI) and an
open infarct-related artery. At the first week, using CMR, wall motion (WM), and four
viability indexes were determined: wall thickness, WM improvement with low-dose dobut-
amine, perfusion, and transmural extent of necrosis. We created a comprehensive score based
on the presence and the relative power of these viability indexes for predicting normal WM
at the sixth month.
RESULTS Of 153 dysfunctional segments at the first week, 59 (39%) exhibited normal WM at the sixth
month. According to the odds ratio of viability indexes for predicting normal WM, we
developed a five-level predictive score. The proportions of segments showing normal WM at
sixth month were as follows; Level 1 (0 indexes): 0 of 13 (0%); Level 2 (normal thickness
and/or perfusion): 14 of 82 (17%); Level 3 (dobutamine response): 5 of 11 (45%); Level 4
(non-transmural necrosis): 20 of 26 (77%); Level 5 (non-transmural necrosis and dobutamine
response): 20 of 21 (95%), p  0.0001 for the trend. These proportions were similar in a
matched prospective validation group comprising 16 patients (0%, 18%, 62%, 77%, and 90%
for levels 1 to 5, respectively, p  0.0001 for the trend).
CONCLUSIONS A comprehensive analysis of the four more widely used CMR-derived viability indexes is
useful for predicting late systolic function after myocardial infarction. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.07.0392005;46:1747–52) © 2005 by the American College of Cardiology Foundation
u
u
M
M
T
s
M
i
f
i
t
c
p
r
t
a
S
phe analysis of residual myocardial viability in the infarcted
rea is of paramount importance when defining the outcome
nd management of patients after myocardial infarction
MI) (1,2). It has been demonstrated that, separately, wall
hickness, contractile reserve, perfusion, and transmural
xtent of necrosis are useful tools for predicting late systolic
ecovery (3–8). However, the relative value of these indexes
s different, and an integrated analysis might allow a more
ccurate prediction. This type of comprehensive assessment
as proved its utility in other clinical scenarios (9–11).
Cardiovascular magnetic resonance (CMR) imaging per-
its, in a single session, a simultaneous state-of-the-art anal-
sis of these parameters (6,7,12). Focusing on a single variable
ay dismiss relevant information easily obtainable by a com-
lete evaluation of the CMR study. We aimed to evaluate the
From the *Cardiology Department, Hospital Clínico y Universitario de Valencia,
niversidad de Valencia, Valencia, Spain; and the †Cardiovascular Magnetic Reso-
ance Imaging Unit, ERESA, Valencia, Spain. Supported by the Spanish Ministry of
ealth (RECAVA-FIS and PI030013 grants).t
Manuscript received April 27, 2005; revised manuscript received June 11, 2005,
ccepted July 6, 2005.sefulness of a comprehensive assessment of these four widely
sed viability indexes for predicting late systolic function after
I in the setting of myocardial stunning.
ETHODS
his study is a part of an ongoing protocol investigating
everal aspects of viability, perfusion, and remodeling after
I (3,6,13). We created a comprehensive score for predict-
ng late systolic function by analyzing the results derived
rom the study group, which comprised the first 40 patients
ncluded in the study protocol. Afterwards, this score was
ested in a matched prospective validation group, which
omprised the next 16 patients included in this series. All 56
atients accomplished the inclusion criteria exposed in this
eport. The ethics committee of our institution approved
he research protocol. Informed consent was obtained from
ll subjects.
tudy group. We prospectively included 60 consecutive
atients with a first ST-segment elevation MI treated with
hrombolytic therapy within the first 6 h after the onset of
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Comprehensive Assessment of Viability November 1, 2005:1747–52hest pain. The inclusion criteria were: 1) stable clinical
ourse without complications during the first six months; 2)
ingle-vessel disease and a patent (Thrombolysis In Myo-
ardial Infarction [TIMI] flow grade 3 and residual stenosis
50%) in the infarct-related artery (IRA) at the end of
re-discharge cardiac catheterization and at the sixth
onth; and 3) no contraindications to CMR. We excluded
0 patients because of multivessel disease (10 cases), TIMI
ow grade 3 (2 cases), restenosis (5 cases), claustrophobia
2 cases), and re-infarction (1 case). Therefore, the final
tudy group comprised 40 patients.
ardiac catheterization. Cardiac catheterization was per-
ormed 4  1 days after MI. A stent was placed in 33
atients (82%) in whom luminal narrowing in the IRA was
50%. At the end of the pre-discharge study, all patients
howed TIMI flow grade 3 and residual stenosis 50%.
ngiographic data were evaluated in a core laboratory
ICICOR, Valladolid, Spain). Cardiac catheterization was
epeated 179 8 days after MI, and TIMI flow grade 3 and
esidual stenosis 50% was confirmed in all cases.
MR. We performed CMR (Sonata Magnetom, Siemens,
rlangen, Germany) at 7  1 days (at least 48 h after
ardiac catheterization) and 184  11 days after MI
ccording to our laboratory protocol (6). All images were
cquired by a phased-array body surface coil during breath-
olds and were electrocardiogram-triggered. Cine images
true fast imaging with steady-state precession [TrueFISP],
epetition time/echo time: 3.2/1.6 ms; flip angle: 61°;
atrix: 256  128; slice thickness: 6 mm; temporal resolu-
ion: 26 ms) were acquired in two-, three-, and four-
hamber views and every 1 cm in short-axis views at rest and
uring intravenous infusion of low-dose (10 g/kg/min)
obutamine.
After cine images, a minimum of three short-axis views
basal, midventricular, apical) and two long-axis views were
erformed for first-pass perfusion imaging (TrueFISP, in-
ersion time: 110 ms, repetition time/echo time: 190/1 ms;
ip angle: 49°; matrix: 128  72) after administering 0.1
mol/kg of gadolinium-diethylenetriaminepentaacetic acid
Magnograf, Juste S.A.Q.F., Madrid, Spain) at a flow rate
f 3 ml/s, and acquiring images every other beat in all slices
uring a period of 90 to 120 s.
Late enhancement imaging was performed 10 min after
ontrast injection using a segmented inversion recovery
Abbreviations and Acronyms
CMR  cardiovascular magnetic resonance imaging
IRA  infarct-related artery
MI  myocardial infarction
TIMI  Thrombolysis In Myocardial Infarction
TrueFISP  true fast imaging with steady state
precession
WM  wall motionrueFISP sequence (repetition time/echo time: 2.5/1.1 ms; alice thickness: 6 mm; flip angle: 50°; matrix: 195  192)
nd nullifying myocardial signal.
nalysis of CMR data. An experienced observer who was
linded to all patient data analyzed CMR studies by using
ustomized software (Syngo, Siemens, Erlangen, Ger-
any). Segment location was defined in cine-image se-
uences applying the 16-segment model (14). The same
rojections used in cine images were recalled for analyzing
erfusion (in first-pass perfusion imaging) and the transmu-
al extent of necrosis (in late enhancement imaging). Wall
otion (WM), abnormal if wall thickening at rest (end-
ystolic thickness  end-diastolic thickness) was 2 mm
6,7,15), was quantified in cine images.
Four viability indexes were evaluated: 1) end-diastolic
hickness (abnormal if 5.5 mm) (6,15), and 2) WM
uring low-dose dobutamine (abnormal if 2 mm) (6,7)
ere quantified in cine images. 3) Abnormal perfusion was
efined qualitatively as regions showing hypoenhancement
compared with non-infarcted segments at the same slice) at
he end of the 90- to 120-s acquisition period in first-pass
erfusion imaging (6,12,16,17). Perfusion defects were con-
rmed both in short- and long-axis views to avoid artifacts.
inally, 4) transmural extent of necrosis was defined as
50% in late enhancement imaging (6,7,12,18). In the
MR study performed at the sixth month, WM was
e-evaluated. Normal systolic function at the sixth month
as considered in the case of WM 2 mm.
In a group of 15 patients (240 segments) not included in
his study, we calculated intraobserver agreement with
egard to the presence or not of the cut-off values applied.
ntraobserver agreement on perfusion results was 94%
kappa 0.86) versus 96% (kappa 0.88) on late enhance-
ent imaging and systolic function results (WM and wall
hickness).
tatistical analysis. Continuous data were expressed as the
ean  standard deviation. Comparisons between groups
ere made using chi-square tests for discrete data. We
nalyzed separately the usefulness of the four viability
ndexes evaluated at the first week (1: wall thickness 5.5
m; 2: WM during low-dose dobutamine 2 mm; 3:
ormal perfusion; 4: transmural extent of necrosis 50%)
or predicting normal WM at the sixth month. We calcu-
ated sensitivity, specificity, and positive and negative pre-
ictive values of the four viability indexes evaluated.
A logistic regression model was applied including the
our viability indexes to investigate the relative power of
ach variable for predicting late systolic function. Ac-
ording to the odds ratio magnitude, we constructed a
ve-level score. The percentage of segments with normal
M at the sixth month depending on the score level was
etermined. We used the chi-square test for trend for
omparing percentages.
The utility of this score was tested in a matched prospec-
ive validation group that comprised the next 16 patients
ncluded in the ongoing study protocol (all of whom
ccomplished the inclusion criteria of the initial study
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November 1, 2005:1747–52 Comprehensive Assessment of Viabilityroup). Statistical significance was considered for p  0.05.
he SPSS statistical package (version 11.0, SPSS Inc.,
hicago, Illinois) was used.
ESULTS
he baseline characteristics of the 40 patients included in
he study group are shown in Table 1. According to the
6-segment model (14), the location of segments with
ransmural extent of necrosis in the entire segment group
126 of 640, 20%) was as follows: 66 (53%) in the anterior
rea, 13 (10%) in the lateral area, and 47 in the inferior area
37%). Of 126 segments with transmural extent of necrosis,
02 (81%) were dysfunctional at rest, whereas only 56 of
14 segments without transmural extent of necrosis (11%)
ere dysfunctional at rest (p  0.0001).
Out of 640 segments evaluated, 158 (25%) were dysfunc-
ional at the first week. Five segments were excluded
ecause of unsatisfactory image quality in any of the
ariables evaluated. Therefore, we focused all our analyses
n 153 dysfunctional segments: 83 (54%) in the anterior
rea, 9 (6%) in the lateral area, and 61 (40%) in the inferior
rea. Mean end-diastolic thickness in these segments was
.5 2.8 mm (range, 2.4 to 16.6 mm) and mean end-systolic
hickness was 9.1 2.9 mm (range, 2.4 to 16.9 mm). Of these
53 dysfunctional segments, 59 (39%) showed preserved WM
t the sixth month.
iability indexes and late systolic function. Of 153 dys-
unctional segments at the first week, wall thickness 5.5
m was present in 130 (85%), wall thickening during
Table 1. Characteristics of the Study Group an
Number of patients
Number of segments
Age (yrs)
Males
Hypertension
Smoking
Diabetes
Hypercholesterolemia
Killip class 1
Anterior infarction
Inferior infarction
Catheterization
Stent-treated patients
IIb/IIIa inhibitors
Multivessel disease
TIMI flow grade 3 before stenting
TIMI flow grade 3 after stenting
Magnetic resonance imaging at one week
End-diastolic volume index (ml/m2)
End-systolic volume index (ml/m2)
Ejection fraction (%)
Magnetic resonance imaging at six months
End-diastolic volume index (ml/m2)
End-systolic volume index (ml/m2)
Ejection fraction (%)p  0.3 in all cases between study group and validation group.
TIMI  Thrombolysis In Myocardial Infarction.ow-dose dobutamine 2 mm in 32 (21%), normal perfu-
ion in 78 (51%), and transmural extent of necrosis50% in
7 segments (31%). Segments with wall thickness5.5 mm
howed more frequently normal WM at the sixth month (56
f 130, 43%) than those with wall thickness 5.5 mm (3 of
3, 13%, p  0.006).
Wall thickening during low-dose dobutamine 2 mm at
he first week related to a higher proportion of segments
ith normal WM at the sixth month (25 of 32, 78% vs. 34
f 121, 28% in the case of absence of contractile reserve, p
0.0001). Preserved perfusion at the first week related to
ore probable normal WM at the sixth month (47 of 78,
0% vs. 12 of 75, 16% in the case of abnormal perfusion, p
0.0001). Segments with transmural extent of necrosis
50% more frequently showed normal WM at the sixth
onth (40 of 47, 85%) than those with transmural extent of
ecrosis 50% (19 of 106, 18%, p  0.0001).
Sensitivity, specificity, and positive and negative predic-
ive values of these four viability indexes for predicting
ormal WM at the sixth month are displayed in Table 2. A
ombined analysis of dobutamine response and transmural
xtent of necrosis was performed (Table 3). Depending on
he transmural extent of necrosis, segments were categorized
n three groups: 0% to 25% (n  37 segments), 26% to 75%
n  42 segments), and 76% to 100% (n  74 segments).
he percentages of segments with normal wall thickening at
he sixth month in these three groups were 92%, 38%, and
2%, respectively (p  0.0001 for the trend). Sensitivity,
pecificity, and positive and negative predictive values of
e Validation Group
Study Group Validation Group
40 16
640 256
57  10 58  10
37 (92%) 14 (87%)
16 (40%) 6 (37%)
30 (75%) 11 (69%)
7 (17%) 2 (12%)
15 (37%) 6 (37%)
6 (15%) 4 (25%)
27 (67%) 9 (56%)
13 (33%) 7 (44%)
33 (82%) 14 (87%)
14 (35%) 6 (37%)
0 (0%) 0 (0%)
20 (50%) 7 (44%)
40 (100%) 16 (100%)
72  23 73  18
39  22 40  16
49  13 46  11
70  27 71  15
35  25 34  14
53  14 53  14d th
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ixth month in these three groups are displayed in Table 3.
omprehensive assessment of viability indexes. A mul-
ivariate analysis for predicting normal WM at the sixth
onth was performed, including all viability indexes as
ndependent variables. According to the odds ratio obtained
wall thickness  2.3, 95% confidence interval [CI] 0.5 to
.4, p 0.2; perfusion 2.6, 95% CI 1.01 to 6.9, p 0.05;
esponse to dobutamine  4.4, 95% CI 1.4 to 13.5, p 
.009; non-transmural necrosis 13, 95% CI 4.6 to 36.7, p
0.0001) we created a five-level comprehensive score
epending on the indexes present (indexes with low value:
all thickness and perfusion; intermediate value: response to
obutamine; and high value: non-transmural necrosis).
The percentage of dysfunctional segments with normal
M at the sixth month increased gradually: level 1 (no
ndex present): 0 of 13 (0%); level 2 (wall thickness and/or
erfusion normal; response to dobutamine absent and non-
ransmural necrosis absent): 14 of 82 (17%); level 3 (re-
ponse to dobutamine present; wall thickness and/or perfu-
ion normal or not; non-transmural necrosis absent): 5 of 11
45%); level 4 (non-transmural necrosis present; wall thick-
ess and/or perfusion normal or not; response to dobut-
mine absent): 20 of 26 (77%); and level 5 (response to
obutamine present and non-transmural necrosis present;
all thickness and/or perfusion normal or not): 20 of 21
95%), p  0.0001 for the trend (Fig. 1).
alidation group. No significant difference in baseline
haracteristics was observed between the study group and
he validation group (Table 1). Of 256 segments, 73 were
ysfunctional at the first week (28%). Of these, 31 (42%)
howed preserved WM at the sixth month. The percentage
f segments with normal WM at the sixth month increased
radually: Level 1: 0 of 4 (0%); Level 2: 7 of 38 (18%); Level
: 5 of 8 (62%); Level 4: 10 of 13 (77%); and Level 5: 9 of
0 (90%), p  0.0001 for the trend. When the score was
ncluded in the multivariate analysis along with the four
iability indexes, the only independent variable selected for
redicting normal WM at the sixth month was the score:
dds ratio  3.9, 95% CI 2.1 to 7 for each additional level
p  0.0001).
able 2. Individual Value of Cardiovascular Magnetic Resonance
redicting Normal Segmental Wall Motion at the Sixth Month (
Sensitivity (%) Specific
all thickness 5.5 mm 95 2
all thickening with dobutamine 2 mm 42 9
ormal perfusion 80 6
ransmural extent of necrosis 50% 68 9
able 3. Value of Response to Dobutamine at the First Week (W
egmental Wall Motion at the Sixth Month (Wall Thickening 
Responders (%) Sensitivity (%) Specific
%–25% (n  37) 16/37 (43) 47 10
6%–75% (n  42) 12/42 (29) 44 8
6%–100% (n  74) 4/74 (5) 22 97ISCUSSION
he use of CMR allows the simultaneous assessment of wall
hickness, response to dobutamine, perfusion, and transmu-
al extent of necrosis. The main finding of this work is that
comprehensive and integrated analysis of these indexes
arly after MI is helpful for predicting late systolic function.
iability indexes and late systolic function. Within the
ast decade, it has been clearly established that systolic
ysfunction is not always a definitive status after MI (1–8);
n the presence of residual viable myocardium and an
dequate myocardial perfusion, contractility may normal-
ze—this process being related to a remarkable prognostic
enefit (1,2).
Great efforts have been carried out to detect the presence
f residual viability in the infarcted area. Using different
echniques, researchers have observed that preserved wall
hickness (19), improvement with dobutamine (20,21),
ormal perfusion (3–5), and non-transmural necrosis (6,7)
elate (when analyzed individually) to a higher probability of
ystolic recovery. The use of CMR has emerged as a reliable
ool for evaluating post-infarction patients (12). Moreover,
t allows, in the same session, a simultaneous assessment of
hose indexes mentioned previously without the limitations
mposed by radiation or the echocardiographic window
Fig. 2).
To avoid confusing factors (previous MI, multivessel
isease, or residual lesion in the IRA, which could alter the
nterpretation of viability indexes) and to assure an adequate
picardial perfusion (which permitted myocardial recovery
n the case of residual viability), we included a homogeneous
tudy group composed of patients with a first MI, single-
essel disease, and TIMI flow grade 3 both at the first week
nd at the sixth month after MI.
Using CMR, we confirmed that all four indexes analyzed
ere useful for predicting systolic recovery of dysfunctional
egments. Several issues should be pointed out. First, the
ensitivity and specificity of these variables for identifying
ecovery of WM was different (Table 2). In addition, the
dds ratio and 95% CIs displayed different predictive
alues. Second, wall thickness was a sensitive but not
ging-Derived Viability Indexes Analyzed at the First Week for
Thickening 2 mm)
) Positive Predictive Value (%) Negative Predictive Value (%)
43 87
78 72
60 84
85 82
hickening With Dobutamine 2 mm) for Predicting Normal
m) Depending on the Transmural Extent of Necrosis
) Positive Predictive Value (%) Negative Predictive Value (%)
100 14
58 70Ima
Wall
ity (%
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November 1, 2005:1747–52 Comprehensive Assessment of Viabilitypecific index. This lack of specificity was probably due to
he high prevalence of segments with a thickness greater
han the pre-established and widely used (6,15) cut-off value
5.5 mm).
igure 2. Cardiovascular magnetic resonance imaging allowed a simulta-
eous assessment of four viability indexes in the same session. (Upper
anels) Using cine-images, end-diastolic wall thickness and wall thicken-
ng during low-dose dobutamine infusion were quantified. (Lower panels)
igure 1. Percentage of segments with normal wall motion (WM) at the sixth
iability indexes: wall thickness 5.5 mm, normal perfusion, wall thickening
evel 2, wall thickness 5.5 mm and/or normal perfusion should be present.f
xample of a patient with an anterior infarction showing a perfusion defect
left) and transmural necrosis (right) in the anterior territory.Third, the response to dobutamine was highly specific but
ot sensitive for predicting late systolic recovery (sensitivity
50% for all transmural extent of necrosis levels). This low
ensitivity was probably due to the small number of re-
ponders segments soon after MI (Table 3). Similar to
revious studies (21,22) that analyzed patients with chronic
schemic disease before revascularization (hibernation), re-
ponse to dobutamine was very low (5%) in cases with
ransmural extent of necrosis 75%. However, in segments
ith transmural extent of necrosis between 0% and 75%, we
etected contractile reserve less frequently than these studies
21,22). A stunning phenomenon in early phases may
xplain this observation; in fact, in our group we have
eported that the percentage of segments with contractile
eserve increased from 21% at the first week to as much as
0% at the sixth month after MI (13).
Fourth, normal perfusion retained higher sensitivity but
ess specificity than dobutamine and transmural extent of
ecrosis. The coexistence of preserved microvasculature in
ecrotic areas (especially in patients like ours, all of them
aving TIMI flow grade 3) and the presence of segments
ith a transitory microvascular dysfunction early after MI
3–6,16) could lower the specificity of this variable. Finally,
s recently suggested, transmural extent of necrosis appeared
s a reliable variable for predicting late systolic function
6,7,12). The simplicity and strength of this index are
preading its use in daily practice.
omprehensive assessment. As commented on previ-
usly, each CMR-derived viability index exhibited some
eculiarities for predicting systolic recovery. Therefore,
h (wall thickening2 mm) depending on the five-level comprehensive score.
low-dose dobutamine 2 mm, and transmural extent of necrosis 50%. In
index absent;   index present; /  index may be present or absent.montocusing on a single parameter may dismiss relevant infor-
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Comprehensive Assessment of Viability November 1, 2005:1747–52ation that could be easily available with a complete
valuation of the data contained in the CMR study. An
ntegrated analysis seems recommendable for a best
nderstanding of the possibilities of systolic recovery.
his type of comprehensive assessment has been shown
o be useful in works investigating other topics and using
MR (9 –11).
Applying a comprehensive score based on the power of
ach variable in the multivariate analysis, we observed a
radual increase in the rate of segments showing preserved
ate systolic function. In the case of transmural necrosis the
ate was 0% when all other indexes were negative, 17%
hen only low-powered indexes were positive (wall thick-
ess and/or perfusion), and 45% when response to dobu-
amine was detected. In the case of non-transmural necrosis,
he rate was 77% in absence and 95% in presence of
esponse to dobutamine. The validation of these data in a
atched prospective group strengthens the robustness of the
core. Although quantification of transmural extent of necrosis
ay be enough for daily practice viability studies, our results
uggest that a complete assessment is helpful to achieve a more
ccurate and “comprehensive” prediction.
tudy limitations. The results obtained can only be gen-
ralized to patients with characteristics similar to our own.
urther studies including a larger number of patients are
ecessary to confirm our results on a patients basis and to
valuate the clinical implications of these findings.
onclusions. Cardiovascular magnetic resonance allows a
omplete analysis of myocardial viability by means of a
imultaneous study of wall thickness, response to dobu-
amine, perfusion and transmural extent of necrosis. Our
ork clarifies the relative merits of each variable early after
I: the predictive value is low in the case of wall thickness
nd perfusion, intermediate in the case of response to
obutamine and high in the case of transmural extent of
ecrosis. A comprehensive assessment of all four indexes is
elpful and provides a better understanding for predicting
ate systolic recovery rather than a separate analysis of each
arameter.
eprint requests and correspondence: Dr. Vicente Bodí, Cardi-
logy Department, Hospital Clínico y Universitario de Valencia,
lasco Ibáñez 17, 46010, Valencia, Spain. E-mail: vicentbodi@
otmail.com.
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